- February 16, 2026Source: Yale Ventures
Blavatnik Fund for Innovation at Yale to Support 12 Life Sciences Projects in 2026 Spanning Oncology, Diagnostics, Neurology, Kidney and Liver Disease
- January 05, 2026
Researchers Identify Proteins that Spread Parkinson’s Pathology in the Brain
- September 12, 2025Source: Journal of Nuclear Medicine / SNMMI
Novel PET Tracer Detects Synaptic Changes in Spinal Cord and Brain After Spinal Cord Injury
- August 11, 2025
A Genetic Mutation Linked to ALS and Dementia Miswires Gene Expression
- June 30, 2025
Biomedical Research Saves Human Lives
- June 13, 2025
To Understand Alzheimer’s Disease, Researchers Turn to Myelin Sheath
Carol and Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia operates as a central home at Yale for the study of neurology, neuroscience, and immunobiology interactions as they relate to the dementias and specifically Alzheimer's. Alzheimer’s is currently ranked as the seventh leading cause of death in the United States and is the most common cause of dementia among older adults.
About the Ludwig Program
The Carol & Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia will transform the field of neuroinflammation with the goal of identifying new pathways and interactions, facilitating fundamental discoveries across many platforms, and providing new nodes for therapeutic intervention.
Ludwig Pilot Grant Program
This program provides crucial seed money for investigators to explore innovative new directions and gather preliminary data for future funding opportunities.
Ludwig Program Seminar Series
The Carol and Gene Program Seminar Series focuses on neuroimmune interactions and Alzheimer’s Disease or related Dementias. It effectively bridges Yale’s world-class presence in immunobiology and neuroscience to transform our understanding of neuro-immune interactions. Yale and national leaders in the field will present.